These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8943755)

  • 1. Method for quantifying expression of functionally active topoisomerase II in patients with leukaemia.
    Cattan AR; Levett D; Douglas EA; Middleton PG; Taylor PR
    J Clin Pathol; 1996 Oct; 49(10):848-52. PubMed ID: 8943755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.
    Cavalcanti DP; Fragoso SP; Goldenberg S; de Souza W; Motta MC
    Parasitol Res; 2004 Dec; 94(6):439-48. PubMed ID: 15517387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetoplast-associated DNA topoisomerase in Crithidia fasciculata: crosslinking of mitochondrial topoisomerase II to both minicircles and maxicircles in cells treated with the topoisomerase inhibitor VP16.
    Ray DS; Hines JC; Anderson M
    Nucleic Acids Res; 1992 Jul; 20(13):3353-6. PubMed ID: 1321413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput fluorescence flow-injection topoisomerase II inhibition assay.
    Barnabé N; Hasinoff BB
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):263-9. PubMed ID: 11530985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines.
    Brown GA; McPherson JP; Gu L; Hedley DW; Toso R; Deuchars KL; Freedman MH; Goldenberg GJ
    Cancer Res; 1995 Jan; 55(1):78-82. PubMed ID: 7805045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and properties of an etoposide-resistant human leukaemic CCRF-CEM cell line.
    Patel S; Austin CA; Fisher LM
    Anticancer Drug Des; 1990 Feb; 5(1):149-57. PubMed ID: 2156515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.
    Lodge AJ; Hall AG; Reid MM; McIntosh GG; Steward M; Anderson JJ; Horne CH; Angus B
    J Clin Pathol; 2001 Jan; 54(1):31-6. PubMed ID: 11271785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase II-catalyzed DNA decatenation.
    Haldane A; Sullivan DM
    Methods Mol Biol; 2001; 95():13-23. PubMed ID: 11089215
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitochondrial topoisomerase II activity is essential for kinetoplast DNA minicircle segregation.
    Shapiro TA
    Mol Cell Biol; 1994 Jun; 14(6):3660-7. PubMed ID: 8196610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification and characterization of recombinant mitochondrial topoisomerase II of kinetoplastid Crithidia fasciculata in High-five insect cells.
    Wang Y; Tsai YC; Urena-Rivera E; Chen J
    Protein Expr Purif; 2008 Mar; 58(1):122-31. PubMed ID: 18068376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrylamide catalytically inhibits topoisomerase II in V79 cells.
    Sciandrello G; Mauro M; Caradonna F; Catanzaro I; Saverini M; Barbata G
    Toxicol In Vitro; 2010 Apr; 24(3):830-4. PubMed ID: 20006698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of DNA topoisomerase II in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and RT-PCR.
    Stammler G; Sauerbrey A; Volm M
    Cancer Lett; 1994 Sep; 84(2):141-7. PubMed ID: 8076370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors.
    Wolverton JS; Danks MK; Granzen B; Beck WT
    Cancer Res; 1992 Aug; 52(15):4248-53. PubMed ID: 1322239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles.
    Shapiro TA; Showalter AF
    Mol Cell Biol; 1994 Sep; 14(9):5891-7. PubMed ID: 8065322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
    Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
    Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-independent DNA topoisomerase II as potential drug target in trypanosomes.
    Douc-Rasy S; Riou JF; Ahomadegbe JC; Riou G
    Biol Cell; 1988; 64(2):145-56. PubMed ID: 2852517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells.
    Danks MK; Warmoth MR; Friche E; Granzen B; Bugg BY; Harker WG; Zwelling LA; Futscher BW; Suttle DP; Beck WT
    Cancer Res; 1993 Mar; 53(6):1373-9. PubMed ID: 8383009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
    Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
    Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II topoisomerase activity in trypanosome mitochondria.
    Shapiro TA; Klein VA; Englund PT
    J Biol Chem; 1989 Mar; 264(7):4173-8. PubMed ID: 2537308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.